Active Ingredient(s):Repaglinide FDA Approved: * December 22, 1997 Pharm Company: *NOVO NORDISK INC Category:Diabetes
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas; like other antidiabetic drugs, a main side effect concern is hypoglycemia. It is sold by Novo Nordisk unde...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion